United States Healthcare Equipment & Supplies

Intuitive Surgical Inc (ISRG)

Track

Over the past 90 days, Intuitive Surgical insiders have executed 24 transactions, all of which were sales totaling approximately $25.74 million. Notable activity includes planned and proposed sales by executives and directors, including Mark Brosius, Gary Loeb, Amal Johnson, and Iman Jeddi. These transactions occurred following the company's April 2026 earnings report.

No active insider signal

Not featured in screeners

Featured in screeners

No active insider signal

Not featured in screeners

Ticker: ISRG Exchange: NSM

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signal detected

10 activity signals detected for Intuitive Surgical Inc

Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Intuitive Surgical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 10,353 USD

Planned sale 12 Jun 2026

Value US$4,914,136.52 | Price 493.75 | Shares 850

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 9,480 USD

Planned sale 11 Jun 2026

Value US$1,540,799.49 | Price 284.07 | Shares 53,519

Brosius Mark

EVP & Chief Mfg and Supply Cha

2 sales — total 19,510 USD

Planned sale 10 Jun 2026

Value US$9,755.22 | Price 424.14 | Shares 23

Planned sale 10 Jun 2026

Value US$9,755.22 | Price 424.14 | Shares 23

LOEB GARY

EVP & Chief Legal and Complian

1 sale — total 169,656 USD

Planned sale 10 Jun 2026

Value US$169,656.00 | Price 424.14 | Shares 400

GARY LOEB

Officer

1 sale — total 170,644 USD

Proposed sale 10 Jun 2026

Value US$170,644.00 | Price 426.61 | Shares 400

Brosius Mark

EVP & Chief Mfg and Supply Cha

2 sales — total 19,372 USD

Planned sale 9 Jun 2026

Value US$9,685.99 | Price 421.13 | Shares 23

Planned sale 9 Jun 2026

Value US$9,685.99 | Price 421.13 | Shares 23

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 9,663 USD

Planned sale 8 Jun 2026

Value US$9,662.76 | Price 420.12 | Shares 23

MARK BROSIUS

Officer

1 sale — total 280,670 USD

Proposed sale 8 Jun 2026

Value US$280,669.90 | Price 422.06 | Shares 665

AMAL JOHNSON

Director

1 sale — total 5,017,486 USD

Proposed sale 3 Jun 2026

Value US$5,017,485.60 | Price 402.30 | Shares 12,472

Jeddi Iman

SVP & GM da Vinci Platforms &

1 sale — total 2,365,594 USD

Planned sale 1 Jun 2026

Value US$2,365,593.75 | Price 420.55 | Shares 5,625

IMAN JEDDI

Officer

1 sale — total 2,365,594 USD

Proposed sale 1 Jun 2026

Value US$2,365,593.75 | Price 420.55 | Shares 5,625

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 7,916 USD

Planned sale 22 May 2026

Value US$7,916.40 | Price 439.80 | Shares 18

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 8,029 USD

Planned sale 21 May 2026

Value US$8,028.72 | Price 446.04 | Shares 18

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 7,927 USD

Planned sale 20 May 2026

Value US$7,926.84 | Price 440.38 | Shares 18

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 7,933 USD

Planned sale 19 May 2026

Value US$7,932.60 | Price 440.70 | Shares 18

Brosius Mark

EVP & Chief Mfg and Supply Cha

1 sale — total 7,604 USD

Planned sale 18 May 2026

Value US$7,604.46 | Price 422.47 | Shares 18

LOEB GARY

EVP & Chief Legal and Complian

1 sale — total 178,780 USD

Planned sale 11 May 2026

Value US$178,780.00 | Price 446.95 | Shares 400

GARY LOEB

Officer

1 sale — total 180,024 USD

Proposed sale 11 May 2026

Value US$180,024.00 | Price 450.06 | Shares 400

Ladd Amy L

1 sale — total 55,157 USD

Planned sale 29 Apr 2026

Value US$55,156.50 | Price 463.50 | Shares 119

Ladd Amy L

1 sale — total 236,730 USD

Planned sale 28 Apr 2026

Value US$236,730.00 | Price 473.46 | Shares 500

AMY LADD

Director

1 sale — total 291,543 USD

Proposed sale 28 Apr 2026

Value US$291,542.81 | Price 470.99 | Shares 619

MCADAMS FAMILY REVOCABLE LIVING TR U/A DTD 01/28/2009

Former Officer

1 sale — total 14,323,761 USD

Proposed sale 27 Apr 2026

Value US$14,323,760.72 | Price 470.91 | Shares 30,417

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 51,865 USD

Planned sale 10 Mar 2026

Value US$51,864.75 | Price 493.95 | Shares 105

MYRIAM CURET MCADAMS

Officer

1 sale — total 51,865 USD

Proposed sale 10 Mar 2026

Value US$51,864.75 | Price 493.95 | Shares 105

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 312,831 USD

Planned sale 9 Mar 2026

Value US$312,831.45 | Price 485.01 | Shares 645

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 317,643 USD

Planned sale 6 Mar 2026

Value US$317,643.12 | Price 490.19 | Shares 648

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 320,890 USD

Planned sale 5 Mar 2026

Value US$320,889.60 | Price 495.20 | Shares 648

MARK BROSIUS

Officer

1 sale — total 859,023 USD

Proposed sale 5 Mar 2026

Value US$859,022.52 | Price 501.18 | Shares 1,714

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 1,177,883 USD

Planned sale 4 Mar 2026

Value US$1,177,883.10 | Price 498.68 | Shares 2,362

BRIAN MILLER

Officer

1 sale — total 4,162,411 USD

Proposed sale 4 Mar 2026

Value US$4,162,410.56 | Price 497.42 | Shares 8,368

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 316,289 USD

Planned sale 3 Mar 2026

Value US$316,288.80 | Price 488.10 | Shares 648

Widman Fredrik

VP Corporate Controller

1 sale — total 57,487 USD

Planned sale 3 Mar 2026

Value US$57,487.24 | Price 487.18 | Shares 118

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 2,303,387 USD

Planned sale 3 Mar 2026

Value US$2,303,387.04 | Price 487.18 | Shares 4,728

FREDRIK WIDMAN

Officer

1 sale — total 57,487 USD

Proposed sale 3 Mar 2026

Value US$57,487.24 | Price 487.18 | Shares 118

MARK BROSIUS

Officer

1 sale — total 1,651,024 USD

Proposed sale 3 Mar 2026

Value US$1,651,023.75 | Price 496.25 | Shares 3,327

MYRIAM CURET MCADAMS

Officer

1 sale — total 2,303,387 USD

Proposed sale 3 Mar 2026

Value US$2,303,387.04 | Price 487.18 | Shares 4,728

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 61,574 USD

Planned sale 2 Mar 2026

Value US$61,573.75 | Price 492.59 | Shares 125

MYRIAM CURET MCADAMS

Officer

1 sale — total 61,574 USD

Proposed sale 2 Mar 2026

Value US$61,573.75 | Price 492.59 | Shares 125

Widman Fredrik

VP Corporate Controller

1 sale — total 124,428 USD

Planned sale 27 Feb 2026

Value US$124,427.79 | Price 499.71 | Shares 249

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 1,171,820 USD

Planned sale 27 Feb 2026

Value US$1,171,819.95 | Price 499.71 | Shares 2,345

WADORS PATRICIA L

SVP Chief Human Resources Offi

1 sale — total 109,936 USD

Planned sale 27 Feb 2026

Value US$109,936.20 | Price 499.71 | Shares 220

FREDRIK WIDMAN

Officer

1 sale — total 124,428 USD

Proposed sale 27 Feb 2026

Value US$124,427.79 | Price 499.71 | Shares 249

MYRIAM CURET MCADAMS

Officer

1 sale — total 1,171,820 USD

Proposed sale 27 Feb 2026

Value US$1,171,819.95 | Price 499.71 | Shares 2,345

PATRICIA WADORS

Officer

1 sale — total 109,936 USD

Proposed sale 27 Feb 2026

Value US$109,936.20 | Price 499.71 | Shares 220

BRIAN MILLER

Officer

1 sale — total 319,197 USD

Proposed sale 18 Feb 2026

Value US$319,197.45 | Price 493.35 | Shares 647

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 208,378 USD

Planned sale 11 Feb 2026

Value US$208,378.16 | Price 494.96 | Shares 421

Widman Fredrik

VP Corporate Controller

1 sale — total 65,830 USD

Planned sale 11 Feb 2026

Value US$65,829.68 | Price 494.96 | Shares 133

FREDRIK WIDMAN

Officer

1 sale — total 65,830 USD

Proposed sale 11 Feb 2026

Value US$65,829.68 | Price 494.96 | Shares 133

MYRIAM CURET MCADAMS

Officer

1 sale — total 208,378 USD

Proposed sale 11 Feb 2026

Value US$208,378.16 | Price 494.96 | Shares 421

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 51,938 USD

Planned sale 10 Feb 2026

Value US$51,938.25 | Price 494.65 | Shares 105

MYRIAM CURET MCADAMS

Officer

1 sale — total 51,938 USD

Proposed sale 10 Feb 2026

Value US$51,938.25 | Price 494.65 | Shares 105

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 65,523 USD

Planned sale 29 Jan 2026

Value US$65,522.52 | Price 520.02 | Shares 126

MYRIAM CURET MCADAMS

Officer

1 sale — total 65,523 USD

Proposed sale 29 Jan 2026

Value US$65,522.52 | Price 520.02 | Shares 126

Curet Myriam

EVP & Chief Medical Officer

2 sales — total 122,500 USD

Planned sale 27 Jan 2026

Value US$66,576.25 | Price 532.61 | Shares 125

Planned sale 27 Jan 2026

Value US$55,924.05 | Price 532.61 | Shares 105

GUTHART GARY S

4 sales — total 15,963,941 USD

Planned sale 27 Jan 2026

Value US$744,129.12 | Price 531.52 | Shares 1,400

Planned sale 27 Jan 2026

Value US$744,139.90 | Price 531.53 | Shares 1,400

Planned sale 27 Jan 2026

Value US$12,987,403.45 | Price 530.10 | Shares 24,500

Proposed sale 27 Jan 2026

Value US$1,488,269.00 | Price 531.52 | Shares 2,800

GARY S GUTHART

Officer; Director

1 sale — total 12,987,403 USD

Proposed sale 27 Jan 2026

Value US$12,987,403.45 | Price 530.10 | Shares 24,500

MYRIAM CURET MCADAMS

Officer

1 sale — total 122,500 USD

Proposed sale 27 Jan 2026

Value US$122,500.30 | Price 532.61 | Shares 230

Brosius Mark

See Remarks

2 sales — total 508,999 USD

Planned sale 15 Dec 2025

Value US$254,499.36 | Price 548.49 | Shares 464

Planned sale 15 Dec 2025

Value US$254,499.36 | Price 548.49 | Shares 464

Brosius Mark

SVP & Chief Mfg and Supply Cha

1 sale — total 2,463,120 USD

Planned sale 12 Dec 2025

Value US$2,463,120.00 | Price 547.36 | Shares 4,500

MARK BROSIUS

Officer

1 sale — total 2,887,871 USD

Proposed sale 12 Dec 2025

Value US$2,887,871.36 | Price 547.36 | Shares 5,276

MYRIAM CURET MCADAMS

Officer

1 sale — total 58,230 USD

Proposed sale 10 Dec 2025

Value US$58,229.60 | Price 559.90 | Shares 104

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 58,230 USD

Planned sale 10 Dec 2025

Value US$58,229.60 | Price 559.90 | Shares 104

Curet Myriam

EVP & Chief Medical Officer

1 sale — total 71,124 USD

Planned sale 1 Dec 2025

Value US$71,123.75 | Price 568.99 | Shares 125

GUTHART GARY S

Executive Chair of the Board o

1 sale — total 13,019,722 USD

Planned sale 1 Dec 2025

Value US$13,019,721.90 | Price 570.89 | Shares 22,806

GARY S GUTHART

Officer; Director

1 sale — total 13,019,722 USD

Proposed sale 1 Dec 2025

Value US$13,019,721.90 | Price 570.89 | Shares 22,806

MYRIAM CURET MCADAMS

Officer

1 sale — total 71,124 USD

Proposed sale 1 Dec 2025

Value US$71,123.75 | Price 568.99 | Shares 125

Charlton Henry L

EVP & Chief Commercial and Mkt

2 sales — total 4,426,560 USD

Planned sale 12 Nov 2025

Value US$2,743,980.00 | Price 580.00 | Shares 4,731

Planned sale 12 Nov 2025

Value US$1,682,580.00 | Price 580.00 | Shares 2,901

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-12	2026-06-12	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	850 -8.3% 493.75 US$4,914,137	850 -8.3%	493.75	US$4,914,137
2026-06-12	2026-06-11	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	53,519 -49.1% 284.07 US$1,540,799	53,519 -49.1%	284.07	US$1,540,799
2026-06-10	2026-06-10	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	2,937 -29.0% 305.38 US$2,733,835	2,937 -29.0%	305.38	US$2,733,835
2026-06-10	2026-06-10	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	23 -1.6% 424.14 US$9,755	23 -1.6%	424.14	US$9,755
2026-06-10	2026-06-10	PlS Planned sale	3.1 LOEB GARY EVP & Chief Legal and Complian Officer	400 -6.5% 424.14 US$169,656	400 -6.5%	424.14	US$169,656
2026-06-10	2026-06-10	PrS Proposed sale	3.1 GARY LOEB Officer Officer	400 426.61 US$170,644	400	426.61	US$170,644
2026-06-10	2026-06-09	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	23 -1.5% 421.13 US$9,686	23 -1.5%	421.13	US$9,686
2026-06-10	2026-06-09	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	23 -1.5% 421.13 US$9,686	23 -1.5%	421.13	US$9,686
2026-06-10	2026-06-08	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	23 -1.5% 420.12 US$9,663	23 -1.5%	420.12	US$9,663
2026-06-08	2026-06-08	PrS Proposed sale	MARK BROSIUS Officer Officer	665 422.06 US$280,670	665	422.06	US$280,670
2026-06-03	2026-06-03	PrS Proposed sale	3.4 AMAL JOHNSON Director Non-Executive Director	12,472 402.30 US$5,017,486	12,472	402.30	US$5,017,486
2026-06-02	2026-06-01	PlS Planned sale	Jeddi Iman SVP & GM da Vinci Platforms & Officer	5,625 -46.5% 420.55 US$2,365,594	5,625 -46.5%	420.55	US$2,365,594
2026-06-01	2026-06-01	PrS Proposed sale	IMAN JEDDI Officer Officer	5,625 420.55 US$2,365,594	5,625	420.55	US$2,365,594
2026-05-22	2026-05-22	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	18 -1.2% 439.80 US$7,916	18 -1.2%	439.80	US$7,916
2026-05-22	2026-05-21	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	18 -1.2% 446.04 US$8,029	18 -1.2%	446.04	US$8,029
2026-05-20	2026-05-20	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	18 -1.1% 440.38 US$7,927	18 -1.1%	440.38	US$7,927
2026-05-20	2026-05-19	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	18 -1.1% 440.70 US$7,933	18 -1.1%	440.70	US$7,933
2026-05-20	2026-05-18	PlS Planned sale	Brosius Mark EVP & Chief Mfg and Supply Cha Officer	18 -1.1% 422.47 US$7,604	18 -1.1%	422.47	US$7,604
2026-05-11	2026-05-11	PlS Planned sale	3.1 LOEB GARY EVP & Chief Legal and Complian Officer	400 -6.1% 446.95 US$178,780	400 -6.1%	446.95	US$178,780
2026-05-11	2026-05-11	PrS Proposed sale	3.1 GARY LOEB Officer Officer	400 450.06 US$180,024	400	450.06	US$180,024
2026-04-29	2026-04-29	PlS Planned sale	Ladd Amy L Non-Executive Director	119 -49.8% 463.50 US$55,156	119 -49.8%	463.50	US$55,156
2026-04-29	2026-04-28	PlS Planned sale	Ladd Amy L Non-Executive Director	500 -67.7% 473.46 US$236,730	500 -67.7%	473.46	US$236,730
2026-04-28	2026-04-28	PrS Proposed sale	AMY LADD Director Non-Executive Director	619 470.99 US$291,543	619	470.99	US$291,543
2026-04-27	2026-04-27	PrS Proposed sale	2.4 MCADAMS FAMILY REVOCABLE LIVING TR U/A DTD 01/28/2009 Former Officer Officer	30,417 470.91 US$14,323,761	30,417	470.91	US$14,323,761
2026-03-11	2026-03-10	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	105 -100.0% 493.95 US$51,865	105 -100.0%	493.95	US$51,865
2026-03-10	2026-03-10	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	105 493.95 US$51,865	105	493.95	US$51,865
2026-03-10	2026-03-09	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	645 -28.6% 485.01 US$312,831	645 -28.6%	485.01	US$312,831
2026-03-10	2026-03-06	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	648 -22.3% 490.19 US$317,643	648 -22.3%	490.19	US$317,643
2026-03-05	2026-03-05	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	648 -18.2% 495.20 US$320,890	648 -18.2%	495.20	US$320,890
2026-03-05	2026-03-05	PrS Proposed sale	MARK BROSIUS Officer Officer	1,714 501.18 US$859,023	1,714	501.18	US$859,023
2026-03-05	2026-03-04	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	2,362 -39.9% 498.68 US$1,177,883	2,362 -39.9%	498.68	US$1,177,883
2026-03-04	2026-03-04	PrS Proposed sale	BRIAN MILLER Officer Officer	8,368 497.42 US$4,162,411	8,368	497.42	US$4,162,411
2026-03-05	2026-03-03	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	648 -9.9% 488.10 US$316,289	648 -9.9%	488.10	US$316,289
2026-03-03	2026-03-03	PlS Planned sale	Widman Fredrik VP Corporate Controller Officer	118 -10.3% 487.18 US$57,487	118 -10.3%	487.18	US$57,487
2026-03-03	2026-03-03	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	4,728 -92.0% 487.18 US$2,303,387	4,728 -92.0%	487.18	US$2,303,387
2026-03-03	2026-03-03	PrS Proposed sale	FREDRIK WIDMAN Officer Officer	118 487.18 US$57,487	118	487.18	US$57,487
2026-03-03	2026-03-03	PrS Proposed sale	MARK BROSIUS Officer Officer	3,327 496.25 US$1,651,024	3,327	496.25	US$1,651,024
2026-03-03	2026-03-03	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	4,728 487.18 US$2,303,387	4,728	487.18	US$2,303,387
2026-03-03	2026-03-02	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	125 -2.4% 492.59 US$61,574	125 -2.4%	492.59	US$61,574
2026-03-02	2026-03-02	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	125 492.59 US$61,574	125	492.59	US$61,574
2026-03-03	2026-02-27	PlS Planned sale	Widman Fredrik VP Corporate Controller Officer	249 -21.5% 499.71 US$124,428	249 -21.5%	499.71	US$124,428
2026-03-02	2026-02-27	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	2,345 -85.1% 499.71 US$1,171,820	2,345 -85.1%	499.71	US$1,171,820
2026-02-27	2026-02-27	PlS Planned sale	2.7 WADORS PATRICIA L SVP Chief Human Resources Offi Officer	220 -100.0% 499.71 US$109,936	220 -100.0%	499.71	US$109,936
2026-02-27	2026-02-27	PrS Proposed sale	FREDRIK WIDMAN Officer Officer	249 499.71 US$124,428	249	499.71	US$124,428
2026-02-27	2026-02-27	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	2,345 499.71 US$1,171,820	2,345	499.71	US$1,171,820
2026-02-27	2026-02-27	PrS Proposed sale	2.7 PATRICIA WADORS Officer Officer	220 499.71 US$109,936	220	499.71	US$109,936
2026-02-18	2026-02-18	PrS Proposed sale	BRIAN MILLER Officer Officer	647 493.35 US$319,197	647	493.35	US$319,197
2026-02-11	2026-02-11	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	421 -50.7% 494.96 US$208,378	421 -50.7%	494.96	US$208,378
2026-02-11	2026-02-11	PlS Planned sale	Widman Fredrik VP Corporate Controller Officer	133 -16.8% 494.96 US$65,830	133 -16.8%	494.96	US$65,830
2026-02-11	2026-02-11	PrS Proposed sale	FREDRIK WIDMAN Officer Officer	133 494.96 US$65,830	133	494.96	US$65,830
2026-02-11	2026-02-11	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	421 494.96 US$208,378	421	494.96	US$208,378
2026-02-11	2026-02-10	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	105 -11.2% 494.65 US$51,938	105 -11.2%	494.65	US$51,938
2026-02-10	2026-02-10	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	105 494.65 US$51,938	105	494.65	US$51,938
2026-01-30	2026-01-29	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	126 -100.0% 520.02 US$65,523	126 -100.0%	520.02	US$65,523
2026-01-29	2026-01-29	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	126 520.02 US$65,523	126	520.02	US$65,523
2026-01-28	2026-01-27	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	125 -100.0% 532.61 US$66,576	125 -100.0%	532.61	US$66,576
2026-01-28	2026-01-27	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	105 -100.0% 532.61 US$55,924	105 -100.0%	532.61	US$55,924
2026-01-28	2026-01-27	PlS Planned sale	GUTHART GARY S Non-Executive Director	1,400 -8.2% 531.52 US$744,129	1,400 -8.2%	531.52	US$744,129
2026-01-28	2026-01-27	PlS Planned sale	GUTHART GARY S Non-Executive Director	1,400 -8.2% 531.53 US$744,140	1,400 -8.2%	531.53	US$744,140
2026-01-28	2026-01-27	PlS Planned sale	GUTHART GARY S Non-Executive Director	24,500 -86.9% 530.10 US$12,987,403	24,500 -86.9%	530.10	US$12,987,403
2026-01-27	2026-01-27	PrS Proposed sale	GARY S GUTHART Officer; Director Executive Director	24,500 530.10 US$12,987,403	24,500	530.10	US$12,987,403
2026-01-27	2026-01-27	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	230 532.61 US$122,500	230	532.61	US$122,500
2026-01-27	2026-01-27	PrS Proposed sale	GUTHART GARY S Officer; Director Executive Director	2,800 531.52 US$1,488,269	2,800	531.52	US$1,488,269
2025-12-17	2025-12-15	PlS Planned sale	Brosius Mark See Remarks Officer	464 -78.0% 548.49 US$254,499	464 -78.0%	548.49	US$254,499
2025-12-15	2025-12-15	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	464 -51.2% 548.49 US$254,499	464 -51.2%	548.49	US$254,499
2025-12-15	2025-12-12	PlS Planned sale	Brosius Mark SVP & Chief Mfg and Supply Cha Officer	4,500 -83.2% 547.36 US$2,463,120	4,500 -83.2%	547.36	US$2,463,120
2025-12-12	2025-12-12	PrS Proposed sale	MARK BROSIUS Officer Officer	5,276 547.36 US$2,887,871	5,276	547.36	US$2,887,871
2025-12-10	2025-12-10	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	104 559.90 US$58,230	104	559.90	US$58,230
2025-12-10	2025-12-10	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	104 -100.0% 559.90 US$58,230	104 -100.0%	559.90	US$58,230
2025-12-02	2025-12-01	PlS Planned sale	2.4 Curet Myriam EVP & Chief Medical Officer Officer	125 -100.0% 568.99 US$71,124	125 -100.0%	568.99	US$71,124
2025-12-02	2025-12-01	PlS Planned sale	GUTHART GARY S Executive Chair of the Board o Executive Director	22,806 -89.4% 570.89 US$13,019,722	22,806 -89.4%	570.89	US$13,019,722
2025-12-01	2025-12-01	PrS Proposed sale	GARY S GUTHART Officer; Director Executive Director	22,806 570.89 US$13,019,722	22,806	570.89	US$13,019,722
2025-12-01	2025-12-01	PrS Proposed sale	2.4 MYRIAM CURET MCADAMS Officer Officer	125 568.99 US$71,124	125	568.99	US$71,124
2025-11-13	2025-11-12	PlS Planned sale	Charlton Henry L EVP & Chief Commercial and Mkt Officer	4,731 -60.8% 580.00 US$2,743,980	4,731 -60.8%	580.00	US$2,743,980
2025-11-13	2025-11-12	PlS Planned sale	Charlton Henry L EVP & Chief Commercial and Mkt Officer	2,901 -27.1% 580.00 US$1,682,580	2,901 -27.1%	580.00	US$1,682,580